PlushCare's membership and visit fees stay fixed at every dose level, but medication cost varies by pharmacy, insurance, and drug tier. Here's what changes and what doesn't when your provider titrates your GLP-1.

LifeMD raises medication costs when your semaglutide or tirzepatide dose increases. Here's what dose-tiered pricing means for your 12-month budget.

Hims & Hers advertises compounded semaglutide at $199/month (six-month prepaid per-month rate), but the company does not publicly disclose whether that rate applies to all doses or changes when your provider increases your prescription strength.

We compare pricing, dose policies, and service transparency across seventeen telehealth providers offering high-dose tirzepatide in 2026. Compounded programs run $249–$399 monthly; branded Zepbound pathways add membership overhead.

Several telehealth GLP-1 programs hold prices flat as doses climb, while others raise monthly costs by $50 to $100 per tier. We compared nine providers that do not increase price with dose, calculated true 12-month costs, and identified which structure fits your budget and timeline.

Hit a GLP-1 plateau on semaglutide or tirzepatide? Walk the 7-step diagnostic, the dose-escalation playbook, the semaglutide-to-tirzepatide switch decision, GLP-Squared dual-compound therapy for resistant cases, and the GLP1R/GIPR genetic angle that explains why population-average titration fails some patients.